(26 days)
No
The description focuses on the material composition and physical properties of a surgical mesh, with no mention of AI or ML technologies.
Yes
The device is used for the "treatment of incisional hernias, abdominal wall repair and parietal (i.e. pertaining to the walls) reinforcement of tissues," which are therapeutic applications.
No
Explanation: The device is a surgical mesh used for tissue reinforcement during surgical repair, not for diagnosing medical conditions.
No
The device is a physical mesh implant made of polyester and collagen, clearly described as a hardware component for surgical repair.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use is for the "reinforcement of tissues during surgical repair" and "treatment of incisional hernias, abdominal wall repair and parietal reinforcement of tissues." This describes a device used in vivo (within the body) during a surgical procedure.
- Device Description: The description details a surgical mesh made of polyester and collagen, designed to be implanted in the body.
- Lack of IVD Characteristics: An IVD is a device used to examine specimens derived from the human body (like blood, urine, tissue) to provide information for diagnosis, monitoring, or screening. This device does not interact with or analyze such specimens.
The information provided clearly indicates this is a surgical implant, not an in vitro diagnostic device.
N/A
Intended Use / Indications for Use
The PARIETEX™ Optimized Composite Mesh (PCO) is used for the reinforcement of tissues during surgical repair.
It is indicated for the treatment of incisional hernias, abdominal wall repair and parietal (i.e. pertaining to the walls) reinforcement of tissues.
The PARIETEX™ Optimized Composite mesh is used for the reinforcement of tissues during surgical repair. It is indicated for the treatment of incisional hernias, abdominal wall repair and parietal (i.e. pertaining to the walls) reinforcement of tissues. The non-absorbable three-dimensional polyester mesh provides long term reinforcement of soft tissues. On the opposite side, the absorbable hydrophilic film minimizes tissue attachment to the mesh in case of direct contact with the viscera.
Product codes
FTL
Device Description
The PARIETEX™ Optimized Composite Mesh (PCO) is available in rectangular and round shape. This device is made out of a three-dimensional multifilament polyester knit for wall reinforcement, covered with an absorbable, continuous and hydrophilic film on one of its sides. This film is made up of collagen from porcine origin and glycerol, and juts out 5 mm over the edge of the reinforcement.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance data: Bench testing and pre-clinical testing has been conducted to evaluate the performance characteristics. Testing has shown that the PARIETEX™ Optimized Composite Mesh is equivalent in performance characteristics to the predicates PARIETEX™ Composite Mesh.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
PARIETEX™ Composite Mesh (K002699 and K040998)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.3300 Surgical mesh.
(a)
Identification. Surgical mesh is a metallic or polymeric screen intended to be implanted to reinforce soft tissue or bone where weakness exists. Examples of surgical mesh are metallic and polymeric mesh for hernia repair, and acetabular and cement restrictor mesh used during orthopedic surgery.(b)
Classification. Class II.
0
K110812
Pg. 1 of 2
APR 1 9 2011
510(k) Summary of Safety and Effectiveness
| Submitter Information | |
|---|---|
| Name: | Sofradim Production |
| Address: | 116 avenue du Formans |
| 01600 Trevoux | |
| France | |
| Phone number: | +33 (0) 4 74 08 90 00 |
| Fax number: | +33 (0) 4 74 08 90 02 |
| Establishment Registration: | 9615742 |
| Name of contact person: | James McMahon |
| Manager, Regulatory Affairs | |
| Covidien | |
| 15 Crosby drive | |
| Bedford, MA 01730 USA | |
| Phone: (781) 839 1787 | |
| Date prepared: | April 15, 2011 |
| Name of device | |
| Trade or proprietary name: | PARIETEX™ Optimized Composite Mesh |
| Common or usual name: | Surgical Mesh |
| Classification name: | Mesh, Surgical, Polymeric |
| Classification panel: | General and Plastic Surgery (79) |
| Regulation: | 21 CFR 878.3300 |
| Product Code: | FTL |
| Legally marketed devices to | |
| which equivalence is claimed: | PARIETEX™ Composite Mesh (K002699 and K040998) |
| Reason for 510(k) submission: | The proposed PARIETEX™ Optimized Composite Mesh has |
| been modified compared to the predicate devices as the knitting | |
| textile has been modified to obtain a higher mechanical | |
| resistance of the mesh and the collagen film formulation has | |
| been changed to get a film more resistant to handling. | |
| Device description: | The PARIETEX™ Optimized Composite Mesh (PCO) is |
| available in rectangular and round shape. This device is made | |
| out of a three-dimensional multifilament polyester knit for wall | |
| reinforcement, covered with an absorbable, continuous and | |
| hydrophilic film on one of its sides. This film is made up of | |
| collagen from porcine origin and glycerol, and juts out 5 mm | |
| over the edge of the reinforcement. | |
| Intended use of the device: | The PARIETEX™ Optimized Composite Mesh (PCO) is used |
| for the reinforcement of tissues during surgical repair. | |
| Indications for use: | It is indicated for the treatment of incisional hernias, abdominal |
| wall repair and parietal (i.e. pertaining to the walls) |
1
reinforcement of tissues. The non-absorbable threedimensional polyester mesh provides long term reinforcement of soft tissues. On the opposite side, the absorbable hydrophilic film minimizes tissue attachment to the mesh in case of direct contact with the viscera.
Summary comparing the technological characteristics of the subject and predicate devices:
The subject PARIETEX™ Optimized Composite Mesh (PCO) is equivalent to the predicate devices PARIETEX™ Composite Mesh (K002699 and K040998) in terms of its technological characteristics. No major technological changes are proposed to the predicate devices in this submission. Design modifications included a new collagen film formulation and changes to the knitting. Performance testing was performed on both predicate and proposed mesh. The results of a pre-clinical study and bench testing, performed in accordance with FDA's Guidance for the Preparation of a Premarket Notification Application for Surgical Mesh, demonstrate improved mechanical properties, and equivalent in-vivo minimizing tissue attachment property.
Performance data: Bench testing and pre-clinical testing has been conducted to evaluate the performance characteristics. Testing has shown that the PARIETEX™ Optimized Composite Mesh is equivalent in performance characteristics to the predicates PARIETEX™ Composite Mesh.
2
Image /page/2/Picture/1 description: The image shows the seal of the Department of Health & Human Services (HHS) of the United States. The seal features a stylized eagle with its wings spread, symbolizing protection and service. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the eagle, indicating the department's name and national affiliation. The seal is presented in black and white, emphasizing its official and governmental nature.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room W-066-0609 Silver Spring, MD 20993-0002
APR 1 9 2011
Sofradim Production % Covidien Mr. James McMahon 15 Crosby Drive Bedford, Massachusetts 01730
Re: K110815
Trade/Device Name: PARIETEX™ Optimized Composite Mesh Regulation Number: 21 CFR 878.3300 Regulation Name: Surgical mesh Regulatory Class: II Product Code: FTL Dated: March 22, 2011 Received: March 25, 2011
Dear Mr. McMahon:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21
3
Page 2 - Mr. James McMahon
CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.lda.gov/AboutFDA/CentersOffices/CDRH/CDRHQffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportalProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
A.S. B. Rih
for
Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications For Use
510(k) Number (if known):
Device Name: PARIETEX™ Optimized Composite Mesh
Indications_For Use:
The PARIETEX™ Optimized Composite mesh is used for the reinforcement of tissues during surgical repair. It is indicated for the treatment of incisional hernias, abdominal wall repair and parietal (i.e. pertaining to the walls) reinforcement of tissues. The non-absorbable three-dimensional polyester mesh provides long term reinforcement of soft tissues. On the opposite side, the absorbable hydrophilic film minimizes tissue attachment to the mesh in case of direct contact with the viscera.
Prescription Use × (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| (Division Sign-Off) | ||
|---|---|---|
| -- | ---------------------------------------------------------------------------------------- | -- |
Division of Surgical, Orthopedic, and Restorative Devices
| Covidien
Premarket Notification | Page 18
TM Trademark |
| ------------------------------------ | ------------------------------------ |
|---|
510(k) Number 